Tessmer James F
VP, Finance & Accounting at LXRX
- Sold, on record
- $388k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 15, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LXRXLEXICON PHARMACEUTICALS, INC.VP, Finance & Accounting
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale LXRXUnusualMay 23, 2016 2016
Sold 6,000 shares at $13.00 ($78k)
Tessmer James F, VP, Finance & Accounting
Sold 27.3% of holdings ($285k position)15,946 shares leftFirst sale on recordFiling
- 2 Form 4 sale LXRXPlan not statedJun 6, 2016 +14 days
Sold 1,500 shares at $15.00 ($23k)
Tessmer James F, VP, Finance & Accounting
Sold 8.6% of holdings ($262k position)15,946 shares leftFiling
- 3 Form 4 sale LXRXUnusualJun 8, 2018 +732 days
Sold 10,000 shares at $12.91 ($129k)
Tessmer James F, VP, Finance & Accounting
Sold 28.1% of holdings ($460k position)25,643 shares leftFirst sale on recordFiling
- 4 Form 4 sale LXRXPlan not statedMar 15, 2021 +1011 days
Sold 22,912 shares at $6.92 ($158k)
Tessmer James F, VP, Finance & Accounting
Sold 24.2% of holdings ($655k position)71,766 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2021 | Mar 16, 2021 | LXRX | VP, Finance & Accounting | Form 4 sale | 22,912 | $158k | 24.2% | Plan not stated | SEC |
| Jun 8, 2018 | Jun 12, 2018 | LXRX | VP, Finance & Accounting | Form 4 sale | 10,000 | $129k | 28.1% | Unusual | SEC |
| Jun 6, 2016 | Jun 8, 2016 | LXRX | VP, Finance & Accounting | Form 4 sale | 1,500 | $23k | 8.6% | Plan not stated | SEC |
| May 23, 2016 | May 23, 2016 | LXRX | VP, Finance & Accounting | Form 4 sale | 6,000 | $78k | 27.3% | Unusual | SEC |